Results 241 to 250 of about 399,690 (387)

Live attenuated SARS-CoV-2 vaccine OTS-228 demonstrates efficacy, safety, and stability in preclinical model. [PDF]

open access: yesNPJ Vaccines
Britzke T   +11 more
europepmc   +1 more source

The antigenicity of serum proteins and their role in xenograft rejection [PDF]

open access: yes, 1996
Celli, S   +9 more
core  

Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins

open access: yesNature Biotechnology, 2010
C. Bosques   +14 more
semanticscholar   +1 more source

Clioquinol as a new therapy in epilepsy: From preclinical evidence to a proof‐of‐concept clinical study

open access: yesEpilepsia, EarlyView.
Abstract Objective Drug‐resistant epilepsy (DRE) affects >25 million people worldwide and is often associated with neuroinflammation. Increasing evidence links deficiency or malfunctioning of the enzyme phosphoglycerate dehydrogenase (PHGDH), which converts 3‐phosphoglycerate to generate serine and the neurotransmitter glycine, with (drug‐resistant ...
Karin Thevissen   +25 more
wiley   +1 more source

Characterization of a SARS-CoV-2 infection model in golden hamsters with diabetes mellitus. [PDF]

open access: yesVirol Sin
Lin HF   +8 more
europepmc   +1 more source

Drug discovery and preclinical testing of drug candidates for developmental and epileptic encephalopathies

open access: yesEpilepsia, EarlyView.
Abstract Drug development for developmental and epileptic encephalopathies (DEEs) follows different strategies on one hand including disease‐targeting precision medicine approaches considering the genetic variants and pathomechanisms in DEEs and on the other hand including therapeutic approaches with novel targets or second‐generation drug candidates ...
Heidrun Potschka, Daniel Pérez‐Pérez
wiley   +1 more source

Home - About - Disclaimer - Privacy